Skip to content

(1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile

C19H14N6O — CID 163836572

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile
SMILESN#Cc1ccc2c(c1)CC[C@H]2Nc1ccc2[nH]nc(-c3cnco3)c2n1
InChIInChI=1S/C19H14N6O/c20-8-11-1-3-13-12(7-11)2-4-14(13)22-17-6-5-15-18(23-17)19(25-24-15)16-9-21-10-26-16/h1,3,5-7,9-10,14H,2,4H2,(H,22,23)(H,24,25)/t14-/m1/s1
InChIKeyOIGLUTZLJBBDJG-CQSZACIVSA-N
MW342.36 g/mol
LogP3.58
Rot. Bonds3

About (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile

(1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile (PubChem CID 163836572) has the molecular formula C19H14N6O and a molecular weight of 342.36 g/mol. Its IUPAC name is (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile.

Molecular Properties

Compound Name(1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile
PubChem CID163836572
Molecular FormulaC19H14N6O
Molecular Weight342.36 g/mol
Exact Mass342.12
IUPAC Name(1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile
SMILESN#Cc1ccc2c(c1)CC[C@H]2Nc1ccc2[nH]nc(-c3cnco3)c2n1
InChIInChI=1S/C19H14N6O/c20-8-11-1-3-13-12(7-11)2-4-14(13)22-17-6-5-15-18(23-17)19(25-24-15)16-9-21-10-26-16/h1,3,5-7,9-10,14H,2,4H2,(H,22,23)(H,24,25)/t14-/m1/s1
InChIKeyOIGLUTZLJBBDJG-CQSZACIVSA-N
XLogP3.58
TPSA103.42 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500342.36
LogP ≤ 53.58
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile?
The IUPAC name of (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile (CID 163836572) is (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile.
What is the SMILES notation for (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile?
The canonical SMILES for (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile is N#Cc1ccc2c(c1)CC[C@H]2Nc1ccc2[nH]nc(-c3cnco3)c2n1.
What is the InChIKey of (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile?
The InChIKey is OIGLUTZLJBBDJG-CQSZACIVSA-N. The full InChI is InChI=1S/C19H14N6O/c20-8-11-1-3-13-12(7-11)2-4-14(13)22-17-6-5-15-18(23-17)19(25-24-15)16-9-21-10-26-16/h1,3,5-7,9-10,14H,2,4H2,(H,22,23)(H,24,25)/t14-/m1/s1.
What are the key properties of (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile?
(1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile has a molecular weight of 342.36 g/mol, XLogP of 3.58, 3 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1R)-1-[[3-(1,3-oxazol-5-yl)-1H-pyrazolo[4,3-b]pyridin-5-yl]amino]-2,3-dihydro-1H-indene-5-carbonitrile is sourced from PubChem (CID 163836572), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.